Literature DB >> 19657486

Recommendations for the use of albumin and immunoglobulins.

Giancarlo Maria Liumbruno1, Francesco Bennardello, Angela Lattanzio, Pierluigi Piccoli, Gina Rossettias.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19657486      PMCID： PMC2719274          DOI： 10.2450/2009.0094-09

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  182 in total

1.  Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment].

Authors:  S Takei; Y K Arora; S M Walker
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

2.  Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.

Authors:  V Blanchette; P Imbach; M Andrew; M Adams; J McMillan; E Wang; R Milner; K Ali; D Barnard; M Bernstein
Journal:  Lancet       Date:  1994-09-10       Impact factor: 79.321

3.  Immunologically active proteins in intravenous immunoglobulin.

Authors:  L Lam; C F Whitsett; J M McNicholl; T W Hodge; J Hooper
Journal:  Lancet       Date:  1993-09-11       Impact factor: 79.321

4.  Aggravation of minimal change nephrotic syndrome by administration of human albumin.

Authors:  A Yoshimura; T Ideura; S Iwasaki; T Taira; S Koshikawa
Journal:  Clin Nephrol       Date:  1992-03       Impact factor: 0.975

5.  Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

Authors:  N Frickhofen; J L Abkowitz; M Safford; J M Berry; J Antunez-de-Mayolo; A Astrow; R Cohen; I Halperin; L King; D Mintzer
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

6.  Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors.

Authors:  E A Sekul; E J Cupler; M C Dalakas
Journal:  Ann Intern Med       Date:  1994-08-15       Impact factor: 25.391

7.  Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study.

Authors:  E Fassio; R Terg; G Landeira; R Abecasis; M Salemne; A Podesta; P Rodriguez; D Levi; D Kravetz
Journal:  J Hepatol       Date:  1992-03       Impact factor: 25.083

8.  Effect of high-dose intravenous immunoglobulin therapy on blood rheology.

Authors:  W H Reinhart; P E Berchtold
Journal:  Lancet       Date:  1992-03-14       Impact factor: 79.321

9.  Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo.

Authors:  P Aukrust; S S Frøland; N B Liabakk; F Müller; I Nordøy; C Haug; T Espevik
Journal:  Blood       Date:  1994-10-01       Impact factor: 22.113

10.  Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites.

Authors:  F Salerno; S Badalamenti; E Lorenzano; P Moser; P Incerti
Journal:  Hepatology       Date:  1991-04       Impact factor: 17.425
View more
  44 in total

1.  Are intravenous immunoglobulins really inappropriate in acquired von Willebrand syndrome?

Authors:  Augusto B Federici; Valentina Rossi; Elisabetta Sacchi; Massimo Franchini
Journal:  Blood Transfus       Date:  2012-12-22       Impact factor: 3.443

Review 2.  Clinical use of albumin.

Authors:  Paolo Caraceni; Manuel Tufoni; Maria Elena Bonavita
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 3.  The demand for polyvalent immunoglobulins in Italy.

Authors:  Fabio Candura; Monica Lanzoni; Gabriele Calizzani; Samantha Profili; Stefania Vaglio; Simonetta Pupella; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 4.  Clinical use of polyvalent immunoglobulins.

Authors:  Isabella Quinti; Anna Maria Pesce; Livia Bonanni; Carlotta Rubino; Federica Pulvirenti; Cinzia Milito
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 5.  The demand for human albumin in Italy.

Authors:  Stefania Vaglio; Gabriele Calizzani; Monica Lanzoni; Fabio Candura; Samantha Profili; Liviana Catalano; Livia Cannata; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

6.  The clinical use of albumin: a topic for Transfusion Medicine.

Authors:  Claudio Velati
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

Review 7.  The clinical use of albumin: the point of view of a specialist in intensive care.

Authors:  Pietro Caironi; Luciano Gattinoni
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

8.  Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04       Impact factor: 3.443

9.  Transfusion therapy in the peri-operative period.

Authors:  Giuseppe Aprili; Claudio Velati; Giancarlo Maria Liumbruno
Journal:  Blood Transfus       Date:  2011-01       Impact factor: 3.443

10.  Recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn.

Authors:  Francesco Bennardello; Serelina Coluzzi; Giuseppe Curciarello; Tullia Todros; Stefania Villa
Journal:  Blood Transfus       Date:  2015-01       Impact factor: 3.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.